2023 Jan Feb Mar Apr May June July Aug Sept Oct Nov Dec 2025 2024

Infectious Disease - MSBI Schedule, 12/1 to 12/31, 2024   (as of 5:43pm Dec 22)

Sun
12-1
Mon
12-2
Tue
12-3
Wed
12-4
Thu
12-5
Fri
12-6
Sat
12-7
Sun
12-8
Mon
12-9
Tue
12-10
Wed
12-11
Thu
12-12
Fri
12-13
Sat
12-14
Sun
12-15
Mon
12-16
Tue
12-17
Wed
12-18
Thu
12-19
Fri
12-20
Sat
12-21
Sun
12-22
Mon
12-23
Tue
12-24
Wed
12-25
Thu
12-26
Fri
12-27
Sat
12-28
Sun
12-29
Mon
12-30
Tue
12-31
ID Inpatient Consult Day Service-SHSHSHSNSN--SNSNSNSNSN--SNSNSNYSYS--YSYSYSKSYS--PDKS
Weeknights SHSHSHSNSN  SNSNSNSNSN  SNSNSNYSYS  YSYSYSKSYS  PDKS
WeekendsSH     SNSN     SNSN     YSYS     KSKS  

Contact suzanne.franco@mountsinai.org if you have questions.   Schedule last updated Dec 18 16:09 2024.   2024 (23-25) Sanchg15  Jun 17 22

Salomon NadimSN914-672-0851
Perlman DavidPD917-282-5804
Yancovitz StanleyYS917-655-4552
 
Koshy SanjanaKS646-246-5063
Humphreys, Sarah SH    917-679-2752

For antibiotic approval, 24 hours a day, contact MSBI Antibiotic Approval on EPIC secure chart

For Consults please contact the MSBI Infectious Diseases Consult group on EPIC secure chat or the fellow listed on call on AMION

Fellows long distance pager prefix 14620 + pager number.

Administration / Escalation

1 - David Perlman MD, Chief, Infectious Diseases Cell: 917-282-5804

2 - Stanley Yancovitz MD, Fellowship Program Site Director Cell: 917-655-4552

3 - MSBI Hospital Director of Nursing: 212-420-3910

4 - MSBI Hospital Administrator on Duty: 212-420-3900

Infection Prevention

On weekdays, contact the Infection Prevention Department at 212-420-2853. On evenings, nights and weekends, please call the Nursing Supervisor for any bed management/infection prevention issues.

The Nursing Supervisor can reach Infection Prevention On Call at 646-799-6024.

Infection Control Policy #009, Care of the Patient with Communicable Diseases in the Inpatient and Outpatient Setting

Candida auris**

active infection or prior history

Special Contact Precautions 

Clostridium difficile, Sapovirus, Norovirus**

active infection

Special Contact Precautions

CRE, MDR Pseudomonas, MDR Acinetobacter baumannii or any other significant MDR gram negative bacilli **

active infection or prior history within 1 year

Contact Precautions

ESBL

all sites, active infection or prior history

No precautions

MRSA**

active MRSA infection or 1 year history of MRSA in current open wound

Contact Precautions

MRSA

nasal screen (+) or prior history of nasal MRSA

No precautions

VISA/VRSA/HVISA**

active infection or prior history

Contact Precautions

VRE**

No precautions unless resistant to Linezolid and/or Daptomycin, solid organ or hematopoietic stem cell transplant within the last 12 months or NICU patient

**Patients may only be cohorted with a roommate who has the same organism (e.g. CRE+CRE; MDR Acinetobacter + MDR Acinetobacter; MRSA + MRSA)